Latham & Watkins represented Bionomics in the offering.Bionomics Limited, a clinical-stage biopharmaceutical company, has announced the pricing of its initial public offering in the United States of…
Bionomics’ Initial Public Offering
Latham & Watkins represented Bionomics in the offering.Bionomics Limited, a clinical-stage biopharmaceutical company, has announced the pricing of its initial public offering in the United States of…